+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Digital Breast Tomosynthesis Market 2019-2023

  • PDF Icon


  • 115 Pages
  • December 2018
  • Region: Global
  • TechNavio
  • ID: 4721354
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Breast cancer is the most common malignancy in women globally. Out of all cancers breast cancer accounted for the second-largest number of diagnosed cases. The risk associated with breast cancer are also on the rise. Factors such as high body mass index, poor dietary habits, the lack of physical activity, tobacco use, and alcohol consumption significantly contribute to the rise in cancer incidence. Such factors increase the risk of breast cancer prevalence, which, in turn, increase the demand for DBT, thereby driving the growth of the market. The market research analysts have predicted that the digital breast tomosynthesis market will register a CAGR of about 13% by 2023.

Market Overview

Growing popularity of D&B

DBT systems offer several advantages compared with standard 2D digital mammography when used alone. These advantages have led many medical practices to adopt DBT before the acquisition of sufficient clinical-effective data. Therefore, key vendors are increasing their R&D investments to incorporate various advanced features in their DBT systems to enhance precision.

Limitations and drawbacks of DBT

DBT is associated with several potentials limitations and practical drawbacks. Some risks of suing DBT may include increased radiation doses, longer scan times, increasing reading times and many more. Such factors likely to hinder the growth.

For the detailed list of factors that will drive and challenge the growth of the digital breast tomosynthesis market during the 2019-2023, view this report.

Competitive Landscape

The global digital breast tomosynthesis market is highly concentrated owing to the presence of a considerable number of players. The vendors in the market are taking strategic initiatives which includes increasing their R&D investments to introduce technologically advanced DBT systems. This had led the leading vendors which will have high opportunities to capitalize on the needs of the consumers and maximize their revenue. Many international and regional digital breast tomosynthesis companies are vying for their share of the global digital breast tomosynthesis market, and players must differentiate themselves to gain vital traction over their peers.

Table of Contents

  • Preface

  • Currency conversion rates for US$

  • Market ecosystem

  • Market characteristics

  • Market segmentation analysis

  • Market definition

  • Market sizing 2018

  • Market size and forecast 2018-2023

  • Bargaining power of buyers

  • Bargaining power of suppliers

  • Threat of new entrants

  • Threat of substitutes

  • Threat of rivalry

  • Market condition

  • Market segmentation by product

  • Comparison by product

  • 2D/3D combination systems - Market size and forecast 2018-2023

  • Standalone 3D systems - Market size and forecast 2018-2023

  • Market opportunity by product

  • Geographic segmentation

  • Geographic comparison

  • Americas - Market size and forecast 2018-2023

  • EMEA - Market size and forecast 2018-2023

  • APAC - Market size and forecast 2018-2023

  • Key leading countries

  • Market opportunity

  • Market drivers

  • Market challenges

  • Market trends

  • Use of computer-aided detection for DBT

  • Contrast-enhanced imaging and tomosynthesis image-guided biopsy as emerging applications of DBT

  • Increasing focus on developing multimodality imaging systems

  • Overview

  • Landscape disruption

  • Vendors covered

  • Vendor classification

  • Market positioning of vendors


  • GE Healthcare


  • Hologic


  • Siemens Healthineers

  • Research methodology

  • List of abbreviations

List of Exhibits
Exhibit 01: Years in consideration
Exhibit 02: Global Medical Imaging Market
Exhibit 03: Segments of global Medical Imaging Market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Product - Market share 2018-2023 (%)
Exhibit 19: Comparison by product
Exhibit 20: 4D/3D combination systems - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: 4D/3D combination systems - Year-over-year growth 2019-2023 (%)
Exhibit 22: Standalone 3D systems - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Standalone 3D systems - Year-over-year growth 2019-2023 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2018-2023 (%)
Exhibit 27: Geographic comparison
Exhibit 28: Americas - Market size and forecast 2018-2023 ($ millions)
Exhibit 29: Americas - Year-over-year growth 2019-2023 (%)
Exhibit 30: EMEA - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: EMEA - Year-over-year growth 2019-2023 (%)
Exhibit 32: APAC - Market size and forecast 2018-2023 ($ millions)
Exhibit 33: APAC - Year-over-year growth 2019-2023 (%)
Exhibit 34: Key leading countries
Exhibit 35: Market opportunity
Exhibit 36: Decision framework
Exhibit 37: Estimated breast cancer rates in 2018
Exhibit 38: Impact of drivers and challenges
Exhibit 39: Vendor landscape
Exhibit 40: Landscape disruption
Exhibit 41: Vendors covered
Exhibit 42: Vendor classification
Exhibit 43: Market positioning of vendors
Exhibit 44: FUJIFILM - Vendor overview
Exhibit 45: FUJIFILM - Business segments
Exhibit 46: FUJIFILM - Organizational developments
Exhibit 47: FUJIFILM - Geographic focus
Exhibit 48: FUJIFILM - Segment focus
Exhibit 49: FUJIFILM - Key offerings
Exhibit 50: FUJIFILM - Key customers
Exhibit 51: GE Healthcare - Vendor overview
Exhibit 52: GE Healthcare - Business segments
Exhibit 53: GE Healthcare - Organizational developments
Exhibit 54: GE Healthcare - Geographic focus
Exhibit 55: GE Healthcare - Segment focus
Exhibit 56: GE Healthcare - Key offerings
Exhibit 57: GE Healthcare - Key customers
Exhibit 58: GMM (IMS GIOTTO) - Vendor overview
Exhibit 59: GMM (IMS GIOTTO) - Product segments
Exhibit 60: GMM (IMS GIOTTO) - Organizational developments
Exhibit 61: GMM (IMS GIOTTO) - Key offerings
Exhibit 62: GMM (IMS GIOTTO) - Key customers
Exhibit 63: Hologic - Vendor overview
Exhibit 64: Hologic - Business segments
Exhibit 65: Hologic - Organizational developments
Exhibit 66: Hologic - Geographic focus
Exhibit 67: Hologic - Segment focus
Exhibit 68: Hologic - Key offerings
Exhibit 69: Hologic - Key customers
Exhibit 70: PLANMECA (PLANMED) - Vendor overview
Exhibit 71: PLANMECA (PLANMED) - Product segments
Exhibit 72: PLANMECA (PLANMED) - Organizational developments
Exhibit 73: PLANMECA (PLANMED) - Geographic focus
Exhibit 74: PLANMECA (PLANMED) - Key offerings
Exhibit 75: PLANMECA (PLANMED) - Key customers
Exhibit 76: Siemens Healthineers - Vendor overview
Exhibit 77: Siemens Healthineers - Business segments
Exhibit 78: Siemens Healthineers - Organizational developments
Exhibit 79: Siemens Healthineers - Geographic focus
Exhibit 80: Siemens Healthineers - Segment focus
Exhibit 81: Siemens Healthineers - Key offerings
Exhibit 82: Siemens Healthineers - Key customers
Exhibit 83: Validation techniques employed for market sizing
Exhibit 84: List of abbreviations

Executive Summary

Global Digital Breast Tomosynthesis Market 2019-2023

The analyst recognizes the following companies as the key players in the global digital breast tomosynthesis market: FUJIFILM, GE Healthcare, GMM (IMS GIOTTO), Hologic, PLANMECA (PLANMED), Siemens Healthineers.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the contrast- enhanced imaging and tomosynthesis image- guided biopsy as emerging application of DBT.”

According to the report, one of the major drivers for this market is the increasing prevalence of breast cancer, which in turn increase the demand for DBT, thereby driving the growth of the market.

Further, the report states that one of the major factors hindering the growth of this market is the high cost of DBT systems is limiting their adoption among end- users. Apart from cost of the system itself, end- users must bear additional expenses om service contracts and expanding their digital storage capacity to accommodate the large file size of DBT images.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • GE Healthcare
  • Hologic
  • Siemens Healthineers